Zacks Research Issues Negative Estimate for Ovintiv Earnings

Ovintiv Inc. (NYSE:OVV) – Zacks Research decreased their Q1 2027 earnings per share (EPS) estimates for shares of Ovintiv in a report released on Tuesday, February 3rd. Zacks Research analyst Team now anticipates that the company will post earnings per share of $1.14 for the quarter, down from their previous forecast of $1.18. Zacks Research has a “Strong Sell” rating on the stock. The consensus estimate for Ovintiv’s current full-year earnings is $5.59 per share. Zacks Research also issued estimates for Ovintiv’s Q4 2027 earnings at $1.32 EPS and FY2027 earnings at $4.85 EPS.

OVV has been the subject of several other reports. Weiss Ratings reissued a “hold (c-)” rating on shares of Ovintiv in a report on Monday, December 29th. Wells Fargo & Company increased their price objective on Ovintiv from $38.00 to $42.00 and gave the stock an “equal weight” rating in a research report on Tuesday, November 18th. Citigroup reduced their target price on Ovintiv from $54.00 to $52.00 and set a “buy” rating for the company in a research report on Tuesday, November 18th. Morgan Stanley decreased their target price on Ovintiv from $48.00 to $46.00 and set an “equal weight” rating on the stock in a research note on Tuesday, October 14th. Finally, Roth Mkm began coverage on Ovintiv in a report on Monday, October 13th. They issued a “neutral” rating and a $42.00 price target on the stock. One investment analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $51.06.

Ovintiv Price Performance

Shares of NYSE:OVV opened at $44.82 on Thursday. The company has a 50 day moving average of $40.31 and a 200 day moving average of $39.93. The company has a current ratio of 0.45, a quick ratio of 0.45 and a debt-to-equity ratio of 0.43. The stock has a market cap of $11.35 billion, a P/E ratio of 49.26, a P/E/G ratio of 2.58 and a beta of 0.78. Ovintiv has a 12 month low of $29.80 and a 12 month high of $46.24.

Ovintiv (NYSE:OVV) last announced its quarterly earnings results on Tuesday, November 4th. The company reported $1.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.97 by $0.06. Ovintiv had a net margin of 2.64% and a return on equity of 12.22%. The firm had revenue of $2.07 billion for the quarter, compared to the consensus estimate of $1.86 billion.

Insiders Place Their Bets

In other news, COO Gregory Dean Givens sold 50,000 shares of the company’s stock in a transaction dated Friday, December 12th. The stock was sold at an average price of $40.33, for a total value of $2,016,500.00. Following the completion of the transaction, the chief operating officer directly owned 105,867 shares in the company, valued at approximately $4,269,616.11. This represents a 32.08% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.70% of the stock is owned by insiders.

Hedge Funds Weigh In On Ovintiv

Large investors have recently modified their holdings of the company. McIlrath & Eck LLC bought a new position in Ovintiv during the third quarter valued at approximately $31,000. IFP Advisors Inc boosted its stake in shares of Ovintiv by 316.7% in the 2nd quarter. IFP Advisors Inc now owns 846 shares of the company’s stock valued at $32,000 after purchasing an additional 643 shares in the last quarter. HM Payson & Co. purchased a new stake in shares of Ovintiv in the 3rd quarter valued at $36,000. Foster Dykema Cabot & Partners LLC bought a new position in shares of Ovintiv during the 3rd quarter valued at $36,000. Finally, Quent Capital LLC purchased a new position in Ovintiv in the 3rd quarter worth $37,000. 83.81% of the stock is owned by hedge funds and other institutional investors.

Key Headlines Impacting Ovintiv

Here are the key news stories impacting Ovintiv this week:

• Positive Sentiment: National Bankshares analyst flagged upside for OVV, a bullish note that could support the stock if momentum follows. Ovintiv Stock Price Expected to Rise, National Bankshares Analyst Says
• Positive Sentiment: Stephens initiated coverage at Equal Weight, citing operational strength and attractive valuation — this provides a counterpoint to negative research and may limit downside. Ovintiv started Equal Weight at Stephens
• Neutral Sentiment: Zacks has issued a series of small, mixed estimate tweaks across different quarters (some upward, some downward) over Feb. 2–3 — a sign they are re‑modeling forecasts rather than signaling a single catalytic change. Zacks Research notes
• Negative Sentiment: Zacks Research downgraded OVV from Hold to Strong Sell and lowered several EPS forecasts (examples: Q1 2027 to ~$1.14, Q4 2027 to ~$1.32, FY2027 to ~$4.85). That downgrade and downward revisions are the primary catalyst for today’s selling pressure. Zacks downgrade and estimates

Ovintiv Company Profile

Ovintiv Inc is a North American energy company focused on the exploration, development and production of oil, natural gas and natural gas liquids. Formerly known as Encana Corporation, the company rebranded as Ovintiv in January 2020 and established its headquarters in Denver, Colorado. Ovintiv’s upstream portfolio spans multiple unconventional resource plays, reflecting a strategy centered on high-return projects and disciplined capital allocation.

The company’s core business activities include the acquisition and development of acreage in major shale basins across the United States and Canada.